BTG plc (LON:BTG – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 840 ($10.56) and traded as high as GBX 840 ($10.56). BTG shares last traded at GBX 840 ($10.56), with a volume of 271,742 shares.
BTG Stock Performance
The company has a market cap of £3.26 billion and a price-to-earnings ratio of 29.47. The firm has a 50-day moving average price of GBX 840 and a 200 day moving average price of GBX 840.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Recommended Stories
- Five stocks we like better than BTG
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- How Investors Can Find the Best Cheap Dividend Stocks
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- What is the S&P 500 and How It is Distinct from Other Indexes
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
